Zobrazeno 1 - 10
of 13
pro vyhledávání: '"B. G. Mahlandt"'
Publikováno v:
Journal of virological methods. 29(1)
A refined, complement-enhanced, plaque-reduction neutralization test was developed for measuring neutralizing antibodies against Junin (Argentine hemorrhagic fever) virus. The assay measured neutralizing antibodies after natural as well as vaccine-in
Publikováno v:
Journal of Infectious Diseases. 152:218-221
Recently, we evaluated rhesus macaques as a potential disease model for AHF. Three of four low-passage strains of Junin virus that were administered to these animals produced severe disease accurately reflected the clinical features of human AHF. The
Publikováno v:
The Journal of Immunology. 96:727-733
Summary Three components of anthrax toxin (edema factor, protective antigen and lethal factor) were separated and tested singly at three dose levels and in factorial combination (27 treatments) to determine their efficacy as immunogens in a resistant
Publikováno v:
Applied and Environmental Microbiology. 34:330-332
Liter volumes of a human arenavirus pathogen (Machupo) and a nonpathogen (Tacaribe) were concentrated 30 to 100 times in less than 90 min without significant loss of particle infectivity.
Publikováno v:
Journal of medical virology. 22(2)
A nonhuman primate model for Argentine hemorrhagic fever has been developed that closely mimics the human clinical syndrome. Parenteral infection of adult Macaca mulatta with low-passage isolates of two Junin viral strains resulted in distinctive hem
Publikováno v:
Journal of medical virology. 22(2)
Two isolates of Junin virus (Espindola and Ledesma) inoculated into rhesus macaques produced distinct lesions which were strain-constant and similar to reported human cases of Argentine hemorrhagic fever. The Espindola isolate was associated with hem
Publikováno v:
Medicina. 45(2)
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950). 91
Summary Three components of anthrax toxin (edema factor, protective antigen and lethal factor) were separated and tested singly at three dose levels and in factorial combination (27 treatments) to determine their efficacy as immunogens in a resistant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b1fe3539de37755f7efac2317747b6fd
https://doi.org/10.21236/ad0640357
https://doi.org/10.21236/ad0640357
Publikováno v:
Antimicrobial agents and chemotherapy. 10